We get the lowdown on Kindeva’s new, multi-use facility in Bridgeton and trends in the market.
Sponsored By
Kindeva
Right now, there are many changes affecting the regulatory landscape for drug development, particularly in the US. We interviewed Milton Boyer, CEO of Kindeva, at CPHI Frankfurt 2025 to get his thoughts on the challenging landscape, the importance of partnerships, onshoring to the US, and Kindeva’s new, state-of-the-art facility in Bridgeton.
Check out the video!
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
April 11, 2025
3 min read
In the ever volatile, highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.
March 6, 2025
3 min read
And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.
March 10, 2025
3 min read
From geopolitical conflicts to cyber threats, CDMOs must rethink resilience.
March 26, 2025
3 min read
With competition for skilled employees in cell and gene therapy manufacturing high, companies need to ensure they are investing in training and mentorship.